Stay updated on Pembrolizumab for EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for EGFR+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new site revision tag v3.5.4 was added, replacing the previous v3.5.3. This reflects an update to the site's build rather than changes to the study details displayed.
    Difference
    0.1%
    Check dated 2026-05-15T23:21:21.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.3, replacing the previous v3.5.2, indicating a maintenance/update to the website's version.
    Difference
    0.1%
    Check dated 2026-04-30T15:48:53.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and v3.5.0 removed, indicating a minor backend update to the site.
    Difference
    0.1%
    Check dated 2026-04-16T10:53:43.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag 'Revision: v3.5.0' instead of 'Revision: v3.4.3'. This is a minor version update with no impact on the study information.
    Difference
    0.1%
    Check dated 2026-03-18T18:22:43.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:40:06.000Z thumbnail image
  8. Check
    115 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the page removed the government funding lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:19:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.